Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

BACKGROUND: Long term serum urate (SU) lowering to a target of <0.36 mmol/l (6 mg/dl) is recommended for effective gout management. However, many studies have reported low achievement of SU targets. The aim of this cross-sectional study was to examine the clinical and psychological factors associ...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Dalbeth, Nicola, House, Meaghan E, Horne, Anne, Petrie, Keith J, McQueen, Fiona M, Taylor, William J
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2012
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493372/
https://ncbi.nlm.nih.gov/pubmed/22978848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-13-174
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items